PRODUCTS
APIs and intermediates
Number of views:
1000

(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride

This is the intermediate of irutinib. Ibrutinib is a Bruton tyrosine kinase (Btk) inhibitor for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Retail price
0.0
Market price
0.0
Number of views:
1000
CAS:

1701403-10-2
Standard:

ISO9001/14001/18001, Purity 99%
Purity:

Quantity
-
+
Stock:
0
Product description
Parameters

Product Intro

This is the intermediate of irutinib. Ibrutinib is a Bruton tyrosine kinase (Btk) inhibitor for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).


Function

Irutinib can combine with Btk, which is necessary for the formation, differentiation, information transmission and survival of B lymphocytes, irreversibly inhibit the activity of BTK and effectively inhibit the proliferation and survival of tumor cells


Application

Ibrutinib is an inhibitor of BTK kinase. It can covalently bind with cysteine residues in the active center of BTK, so as to inhibit the activity of B cells. It has a significant effect on B-cell lymphoma, especially for patients with a variety of advanced lymphomas that are difficult to relapse.

Keyword:
CAS 1701403-10-2
Intermediates
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
NORKY

Copyright © Shanghai Norky Pharmaceutical Co., Ltd. All Rights Reserved        沪ICP备20013299号        Powered by www.300.cn